Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03366506

Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
12 Years – 120 Years
Healthy volunteers

Summary

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:- 1. Differences between ethnic subgroups 2. Differences between immigrant and native-born populations 3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

Detailed description

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:- 1. Differences between ethnic subgroups 2. Differences between immigrant and native-born populations 3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors. The clinical features will include pattern of onset, details of full clinical exam ( including ALSFRS-R score, power, reflexes, and other signs of upper or lower-motor neuron dysfunction. Correlations between different clinical parameters themselves will be made, as well as correlation between clinical parameters and other epidemiological factors.

Conditions

Interventions

TypeNameDescription
OTHERObservation

Timeline

Start date
2009-03-09
Primary completion
2049-03-01
Completion
2050-01-01
First posted
2017-12-08
Last updated
2021-02-10

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03366506. Inclusion in this directory is not an endorsement.